Cash for care: a simple incentive to keep HIV patients on track

NCT ID NCT05373095

First seen Aug 14, 2026 · Last updated Aug 14, 2026

Summary

This trial tests whether offering small cash payments to people living with HIV, when they attend counseling sessions and clinic visits, can help them stay engaged in care and achieve viral suppression. Participants are adults identified as high risk for dropping out of care at two health facilities in Tanzania. Half will receive standard HIV care, while the other half will also receive up to three cash transfers of about $10 each, paired with enhanced adherence counseling. The study will measure how many participants maintain viral suppression at 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Conditional cash transfers and adapted adherence counseling
What this could lead to
If effective, this approach could offer a simple, scalable way to keep people with HIV engaged in care and improve long-term health outcomes.
What could go wrong
The trial is relatively small and the cash incentive is modest, so the effect may be limited or not generalizable to other settings. Success depends on participants' willingness to attend sessions and adhere to treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV (HUMAN IMMUNODEFICIENCY VIRUS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Geita Regional Referral Hospital

    Geita, Tanzania

  • Geita Town Council Hospital

    Geita, Tanzania

  • Katoro Health Center

    Katoro, Tanzania

  • Nyankumbu Health Center

    Geita, Tanzania

More trials for these conditions

Other studies related to the condition(s) this trial covers.